Inform, Empower, Connect


Trial Status
Trial Type
Trial Phase
Trial Name Status Phase Country City
Study on Clinical Features, Treatment Mode and Survival of Sarcoma

The aim of this trial is to collect information from patients about their sarcoma treatment and outcomes. All the data collected will be from patients who have already undergone treatment. This includ

Recruiting China, Zhengzhou,
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

This trial aims to assess the safety and side effects of the drug YH001 when given with envafolimab with or without doxorubicin. It will also measure whether these drugs may be effective at treating a

Not yet recruiting Phase 1
Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma Patient

The aim of this study is to see if tranexamic acid can prevent blood loss after limb-sparing surgery for bone cancer. Bone cancer includes osteosarcoma. Participants will randomly be split into two gr

Recruiting Early Phase 1 Pakistan, Lahore,
The Effects of Observer Presence and Type on Patients' Perception of Exercise After Bone Tumor Resection-A Qualitative Study

The aim of the study is to investigate how patients find different formats of exercise after surgery. The study will also look for barriers to starting exercise programmes. This study is open to patie

Not yet recruiting Not Applicable Turkey, Istanbul,
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

The purpose of this study was to assess the side effects and best dose of erlotinib when given with temozolomide in treating young patients with cancers that had returned or not responded to initial t

Completed Phase 1 United States, Arcadia,
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

The aim of this trial is to see if PEN-866 can be combined with vincristine and temozolomide to treat childhood cancers. There are two parts to this study and people with osteosarcoma may be able to t

Not yet recruiting Phase 1 United States, Bethesda,
Regorafenib in Patients With Refractory Primary Bone Tumors

This trial will assess the effectiveness of the drug Regorafenib in treating people with osteosarcoma. Participants will be split into two groups. One group will receive Regorafenib and the standard

Recruiting Phase 1 Poland, Warsaw,
GISAR German Interdisciplinary Sarcoma Registry

This is a registry. A registry is a database that collects information about people with a certain condition. In this case, it is for people with sarcoma. This includes osteosarcoma. The data collecte

Recruiting Germany, Bad Saarow, Berlin-Spandau, ...
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately dif

Completed Phase 2 United States, Stanford,
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

The main aim of the trial was to assess the effectiveness of using 77Lu-3BP-227 for patients with advanced cancers expressing the marker neurotensin receptor type 1. This included patients with osteos

Terminated Phase 1 United States, Belgium, Fran... Houston, Brussels, Lyon, Ma...


  • The Osteosarcoma Now trial finder is intended to supplement, not replace, your healthcare team. Patients should always discuss a clinical trial with their healthcare team.  If a patient is eligible for a trial the trial team will be able to provide more in-depth information about the trial so the patient can make an informed decision before taking part. Trial information has been sourced from The content is then reviewed weekly by the Osteosarcoma Now team. All the trials also have a patient-friendly summary and key information section written by the team at Osteosarcoma Now. We have also included a description of the medications being used in the trial and have added some explainer text (In brackets) to the ‘who is this trial (not) for’ sections. To the best of our ability the clinical trial database is up-to-date and accurate however, we cannot assume any liability for the accuracy or completeness of the information.